Antwi, S. O., Van Houten, H. K., Sangaralingham, L. R., & Patel, T. (2019). Risk of de novo hepatocellular carcinoma following use of direct acting antiviral medications for treatment of chronic hepatitis C. Cancer Prev Res (Phila).
Chicago-tyylinen lähdeviittausAntwi, Samuel O., Holly K. Van Houten, Lindsey R. Sangaralingham, ja Tushar Patel. "Risk of De Novo Hepatocellular Carcinoma Following Use of Direct Acting Antiviral Medications for Treatment of Chronic Hepatitis C." Cancer Prev Res (Phila) 2019.
MLA-viiteAntwi, Samuel O., Holly K. Van Houten, Lindsey R. Sangaralingham, ja Tushar Patel. "Risk of De Novo Hepatocellular Carcinoma Following Use of Direct Acting Antiviral Medications for Treatment of Chronic Hepatitis C." Cancer Prev Res (Phila) 2019.